Even though this computational integration of CNV clones and scRNA-seq may not directly transfer to settings with less pronounced genomic aberrations, by linking distinct transcriptional profiles to the identified tumour clones, we were able to highlight differentially activated pathways between clones, including but not limited to MYC and MTOR signalling. This evidence concerns the gene MYC and neoplasm.